Ugo De Giorgi

68PUBLICATIONS
286CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Feb 19, 2026
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Milena Urbini, Thomas F Eleveld, Maurizio Polano

|Nov 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.

Irene Marini, Emilio Francesco Giunta, Silvia Nicolini

|Oct 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer.

Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

|Aug 07, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.

Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier

|Nov 09, 2024
Treatment Strategies for Advanced Endometrial Cancer According to Molecular Classification.

Valentina Tuninetti, Alberto Farolfi, Chiara Rognone

Pageof 12

Frequent Collaborators

12 joint publications

Vincenza Conteduca

10 joint publications

Sebastiano Buti

10 joint publications

Giuseppe Schepisi

9 joint publications

Giorgia Gurioli